Dengue shock syndrome and rhabdomyolysis

Netherlands Journal of Medicine

Volumn 65, Issue 2, 2007, Pages 78-81

  Karakus, A ^a   Banga, N ^a   Voorn, G P ^a   Meinders, A J ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACUTE KIDNEY FAILURE; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEATH; DENGUE; ENDOTRACHEAL INTUBATION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; LABORATORY TEST; LYMPH NODE HYPERPLASIA; MALE; MULTIPLE ORGAN FAILURE; MYOGLOBINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PNEUMONIA; PROTEINURIA; RESPIRATORY FAILURE; RHABDOMYOLYSIS; SALIVARY GLAND DISEASE; SEPTIC SHOCK; THROMBOCYTOPENIA; URINALYSIS;

AGED; DENGUE HEMORRHAGIC FEVER; FATAL OUTCOME; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MYOGLOBINURIA; RHABDOMYOLYSIS;

EID: 33847364951     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cobelens FGJ, Groen J, Osterhaus ADME, et al. Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health 2002;7:331-8.
2. Bakker RC, Veenstra J, Dingemans-Dumas AM, Wetsteyn JCFM, Kager PA. Imported Dengue in the Netherlands. J Travel Med 1996;z3:204-8.
3. World Health Organization. Dengue. Available at http://www.who.int/tdr/ dw/dengue2004.htm; Internet accessed July 15, 2005
4. Jose GRP, et al. Dengue and dengue haemorrhagic fever. Lancet 1998;352:971-7.
5. Thong MK. Dengue shock syndrome and acute respiratory distress syndrome. Lancet 1998;352:1712.
6. Goh AYT, Chan PWK, Lum LCS, Roziah M. Incidence of acute respiratory distress syndrome: a comparison of two definitions. Arch Dis Child 1998;79:256-9.
7. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC. Immunopathogenesis of Dengue Virus Infection. J Biomed Sci 2001;8:377-88.
8. Ngo NT, Cao XT, Kneen R, et al. Acute management of dengue shock syndrome: a randomized double blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001;32:204-13.
9. Delia BB, et al. Noninvasive Measurement of Microvascular Leakage in Patients with Dengue Hemorrhagic Fever. Clin Infect Dis 2001;32:243-53.
10. Pea L, Roda L, Moll F. Desmopressin treatment for a case of dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis 2001;33:1611-2.
11. Chuansumrit A, Wangruansatid S, Lektrakul Y, et al. Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study. Blood Coagul Fibrinolysis 2005;16:549-55.
12. Ostronoff M, Ostronoff F Florencio R, et al. Serious thrombocytopenia due to dengue hemorrhagic fever treated with high dosages of immunoglobin. Clin infect Dis 2003; 36:1623-4.
13. Lum LC, Goh AY, Chan PW, El-Amin AL, Lam SK. Risk factors for hemorrhage in severe dengue infections. J Pediatr 2002;140:629-31.
14. Thisyakorn U, Nimmannitya S. Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis 1993;16:295.
15. Davis JS, Bourke P. Rhabdomyolysis associated with dengue virus infection. Clin Infect Dis 2004;38:e109-11.
16. Lim M, Goh HK. Rhabdomyolysis following dengue virus infection. Singapore Med J 2005;46:645-6.